INTERLEUKIN-5 AND ITS RECEPTOR SYSTEM - IMPLICATIONS IN THE IMMUNE-SYSTEM AND INFLAMMATION

被引:105
作者
TAKATSU, K
TAKAKI, S
HITOSHI, Y
机构
[1] Department of Immunology, Institute of Medical Science, University of Tokyo
来源
ADVANCES IN IMMUNOLOGY, VOL 57 | 1994年 / 57卷
关键词
D O I
10.1016/S0065-2776(08)60673-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The chapter summarizes advances in interleukin-5 (IL-5) and IL-soluble receptor (IL-SR) research in the study of structure, physiologic functions, and the unique modes of receptor-mediated signaling. The chapter also discusses the pathophysiology of aberrant expression of IL-5 and its receptor. Helper T cells recognize antigenic peptide in the context of class IL1 major histocompatibility complex (MHC) molecules on accessory cells and/or B cells and secrete several soluble factors, including IL-4, IL-5, and IL-6, that can induce B-cell growth and the maturation of B cells. Mouse IL-5 (mIL-5) is a glycoprotein induced in T cells after stimulation with an antigen, such as Mycobacterium tuberculosis or Toxocara canis, and in mast cells upon stimulation with allergen/IgE complex or calcium ionophores. The action of IL-5 in responsive cells is the molecular mechanism of signal transduction cascade after IL-5 binding to the functional IL-5 receptor (IL-5R). The IL-5 signals can be transduced through the high-affinity IL-5R that consists of two different polypeptide subunits: α and β. The cDNAs encoding both α - and β -subunits for mIL-5R have been isolated; the α -subunit was found to be a 60 kDa (p60) protein and the β-subunit (a 130-kDa protein, p130) was identified as the protein identical to the β-subunit for mIL-3R and mGM-CSFR, which can convert the low affinity mILSRα into a high-affinity receptor. The study of mIL-5 originated from the search for the B-cell differentiation factor that induces antigen-primed B cells to differentiate into antigen-specific antibody-producing cells or the proliferation of BCLl B-cell tumor cells. © 1994, Academic Press Inc.
引用
收藏
页码:145 / 190
页数:46
相关论文
共 288 条
[1]   STRATEGIES OF ANTICYTOKINE MONOCLONAL-ANTIBODY DEVELOPMENT - IMMUNOASSAY OF IL-10 AND IL-5 IN CLINICAL-SAMPLES [J].
ABRAMS, JS ;
RONCAROLO, MG ;
YSSEL, H ;
ANDERSSON, U ;
GLEICH, GJ ;
SILVER, JE .
IMMUNOLOGICAL REVIEWS, 1992, 127 :5-24
[2]  
ALDERSON MR, 1987, J IMMUNOL, V139, P2656
[3]  
ALLISON KC, 1991, J IMMUNOL, V146, P4197
[4]  
[Anonymous], PROG IMMUNOL, DOI DOI 10.1016/B978-0-12-057550-3.50033-8
[5]   INTERLEUKIN-5 ENHANCES INTERLEUKIN 2-MEDIATED LYMPHOKINE-ACTIVATED KILLER ACTIVITY [J].
AOKI, T ;
KIKUCHI, H ;
MIYATAKE, S ;
ODA, Y ;
IWASAKI, K ;
YAMASAKI, T ;
KINASHI, T ;
HONJO, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (02) :583-588
[6]   CYTOKINES - COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSES [J].
ARAI, K ;
LEE, F ;
MIYAJIMA, A ;
MIYATAKE, S ;
ARAI, N ;
YOKOTA, T .
ANNUAL REVIEW OF BIOCHEMISTRY, 1990, 59 :783-836
[7]   IDENTIFICATION OF JAK2 AS A GROWTH-HORMONE RECEPTOR-ASSOCIATED TYROSINE KINASE [J].
ARGETSINGER, LS ;
CAMPBELL, GS ;
YANG, XN ;
WITTHUHN, BA ;
SILVENNOINEN, O ;
IHLE, JN ;
CARTERSU, C .
CELL, 1993, 74 (02) :237-244
[8]   CLONING OF CDNA FOR HUMAN T-CELL REPLACING FACTOR (INTERLEUKIN-5) AND COMPARISON WITH THE MURINE HOMOLOG [J].
AZUMA, C ;
TANABE, T ;
KONISHI, M ;
KINASHI, T ;
NOMA, T ;
MATSUDA, F ;
YAOITA, Y ;
TAKATSU, K ;
HAMMARSTROM, L ;
SMITH, CIE ;
SEVERINSON, E ;
HONJO, T .
NUCLEIC ACIDS RESEARCH, 1986, 14 (22) :9149-9158
[9]   IDENTIFICATION OF ACTIVATED LYMPHOCYTES-T AND EOSINOPHILS IN BRONCHIAL BIOPSIES IN STABLE ATOPIC ASTHMA [J].
AZZAWI, M ;
BRADLEY, B ;
JEFFERY, PK ;
FREW, AJ ;
WARDLAW, AJ ;
KNOWLES, G ;
ASSOUFI, B ;
COLLINS, JV ;
DURHAM, S ;
KAY, AB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (06) :1407-1413
[10]   CLOSE GENETIC AND PHYSICAL LINKAGE BETWEEN THE MURINE HEMATOPOIETIC GROWTH-FACTOR GENES GM-CSF AND MULTI-CSF (IL3) [J].
BARLOW, DP ;
BUCAN, M ;
LEHRACH, H ;
HOGAN, BIM ;
GOUGH, NM .
EMBO JOURNAL, 1987, 6 (03) :617-623